Pembrolizumab in HER2-Positive Gastric Cancer

被引：3

作者：

Janjigian, Yelena Y. ^{[1
]}

Kawazoe, Akihito ^{[2
]}

Bai, Yuxian ^{[3
]}

Xu, Jianming ^{[4
]}

Lonardi, Sara ^{[5
]}

Metges, Jean Phillipe ^{[6
]}

Yanez, Patricio ^{[7
]}

Wyrwicz, Lucjan S. ^{[8
]}

Shen, Lin ^{[9
]}

Ostapenko, Yuriy ^{[10
]}

Bilici, Mehmet ^{[11
]}

Chung, Hyun Cheol ^{[12
]}

Shitara, Kohei

Qin, Shukui ^{[13
]}

Van Cutsem, Eric ^{[14
]}

Tabernero, Josep ^{[15
]}

Luo, Suxia ^{[16
]}

Mahave, Mauricio ^{[17
]}

Tang, Yong ^{[18
]}

Lowery, Maeve ^{[19
]}

Monteiro, Maria M. F. ^{[20
]}

Xu, Linzhi ^{[21
]}

Shih, Chie-Schin ^{[21
]}

Sharan, Kanu P. ^{[21
]}

Bhagia, Pooja ^{[21
]}

Rha, Sun Young ^{[12
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, New York, NY 10029 USA

[2] Natl Canc Hosp East, Kashiwa, Japan

[3] Harbin Med Univ Canc Hosp, Harbin, Peoples R China

[4] Fifth Med Ctr Peoples Liberat Army, Beijing, Peoples R China

[5] Ist Oncol Veneto, Padua, Italy

[6] Univ Hosp Brest, Brest, France

[7] James Lind Canc Res Ctr, Temuco, Chile

[8] Maria Sklodowska Curie Natl Canc Res Inst, Warsaw, Poland

[9] Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China

[10] Natl Canc Inst, Kiev, Ukraine

[11] Ataturk Univ, Erzurum, Turkiye

[12] Yonsei Canc Ctr, Seoul, South Korea

[13] Canc Ctr Peoples Liberat Army, Nanjing, Peoples R China

[14] Univ Hosp Gasthuisberg, Leuven, Belgium

[15] Vall dHebron Univ Hosp, Inst Oncol, Barcelona, Spain

[16] Henan Canc Hosp, Zhengzhou, Peoples R China

[17] Fdn Arturo Lopez Perez, Santiago, Chile

[18] Xinjiang Med Univ, Canc Hosp, Urumqi, Peoples R China

[19] Trinity St Jamess Canc Inst, Dublin, Ireland

[20] Inst Canc Ceara, Fortaleza, CE, Brazil

[21] Merck, Rahway, NJ USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2024年

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1056/NEJMc2408121

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Pembrolizumab in HER2-Positive Gastric Cancer The addition of pembrolizumab to trastuzumab and chemotherapy in patients with gastric cancer improved both progression-free and overall survival as compared with trastuzumab and chemotherapy alone.

引用

页数：3

共 50 条

[31] Trastuzumab deruxtecan for the treatment of patients with HER2-positive gastric cancer
Kotani, Daisuke
Shitara, Kohei
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
[32] SECOND-LINE TREATMENT OF HER2-POSITIVE GASTRIC CANCER
Hamamoto, Y.
Funakoshi, S.
Higuchi, H.
Takaishi, H.
Hibi, T.
ANNALS OF ONCOLOGY, 2012, 23 : 76 - 76
[33] Long-term trastuzumab (Herceptin®) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer
Mueller, Volkmar
Clemens, Michael
Jassem, Jacek
Al-Sakaff, Nedal
Auclair, Petra
Nuesch, Eveline
Holloway, Debbie
Shing, Mona
Bang, Yung-Jue
BMC CANCER, 2018, 18
[34] Long-term trastuzumab (Herceptin®) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer
Volkmar Müller
Michael Clemens
Jacek Jassem
Nedal Al-Sakaff
Petra Auclair
Eveline Nüesch
Debbie Holloway
Mona Shing
Yung-Jue Bang
BMC Cancer, 18
[35] HER2-positive breast cancer
Loibl, Sibylle
Gianni, Luca
LANCET, 2017, 389 (10087): : 2415 - 2429
[36] HER2-positive advanced gastric cancer: similar HER2-positivity levels to breast cancer
Lordick, F.
Bang, Y. J.
Kang, Y. K.
Otero Reyes, D.
Manikhas, G. M.
Shen, L.
Kulikov, E.
Stoss, O.
Jordan, B. W. M.
Van Cutsem, E.
EJC SUPPLEMENTS, 2007, 5 (04): : 272 - 272
[37] Pembrolizumab for HER2+ gastric cancer
David Killock
Nature Reviews Clinical Oncology, 2022, 19 : 150 - 150
[38] Pembrolizumab for HER2+ gastric cancer
Killock, David
NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (03) : 150 - 150
[39] Cerebrospinal Fluid Cytology Diagnosis of HER2-Positive Leptomeningeal Carcinomatosis From HER2-Positive Metastatic Gastric Cancer: Case Report
Cavanna, Luigi
Rocchi, Andrea
Gorgni, Silvia
Ambroggi, Massimo
Foroni, Raoul P.
Ubbiali, Alessandro
Civardi, Giuseppe
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (13) : E367 - E368
[40] NICE guidance on trastuzumab for the treatment of HER2-positive metastatic gastric cancer
Holden, Joanne
Garrett, Zoe
Stevens, Andrew
LANCET ONCOLOGY, 2011, 12 (01): : 16 - 17

← 1 2 3 4 5 →